Funded Studies Details
2023 Strategic Grant (SG)
Pilot Study “Drug screen targeting the pathological interaction between LSD1 and tau”
David Katz
Emory University
Atlanta, GA - United States
TREAT-AD is a program funded by the National Institution on Aging (NIA) to improve, diversify and reinvigorate the Alzheimer’s disease (AD) drug development pipeline. With funding from the Alzheimer's Association, the team at Emory will perform a drug screen on over 2,000 potential targets to identify and test a novel drug therapy for Alzheimer’s disease treatment. Results from this pilot study will inform future funding applications.
The first survivor of Alzheimer's is out there, but we won't get there without you.
Donate Now
Learn how Alzheimer’s disease affects the brain.
Take the Brain Tour